NEW YORK LIFE INVESTMENT MANAGEMENT LLCNEW YORK LIFE INVESTMENT MANAGEMENT LLC

Institutional investor · Portfolio as of Q4 2020

SEC EDGAR SourceSEC Filings

Top Holdings26 positions

Checking export access…
Activity:
Stock
Shares
Value
Weight
Avg Buy
Est. P&L
Held
Conviction
IQSUIQSU
ETF

NEW YORK LIFE INVESTMENTS ET

10M$322.3M21.6%$27.97+7.82%
3 qtrssince 2020-Q2
Increased
97
CLRGCLRGDelisted
ETF

IQ U.S. Large Cap ETF

9.6M$280.1M18.8%$21.49+29.32%
8 qtrssince 2019-Q1
Decreased
0
IQINIQINDelisted
ETF

NYLI 500 International ETF

8.2M$239.4M16.1%$19.36+32.16%
8 qtrssince 2019-Q1
Decreased
0
HFXIHFXI
ETF

NYLI FTSE INTERNATIONAL EQUITY CURRENCY NEUTRAL ETF

6.8M$155M10.4%$15.66+22.25%
8 qtrssince 2019-Q1
Decreased
0
CSMLCSMLDelisted
ETF

IQ U.S. Small Cap ETF

4.6M$134.5M9.0%$23.75+17.28%
8 qtrssince 2019-Q1
Increased
70
IQSIIQSI
ETF

NEW YORK LIFE INVESTMENTS ET

4.6M$126.7M8.5%$20.13+18.34%
3 qtrssince 2020-Q2
Increased
66
HYLVHYLVDelisted
ETF

IndexIQ ETF Trust IQ S&P High Y

2.2M$57.1M3.8%$24.13+5.31%
3 qtrssince 2020-Q2
Increased
56
GVIGVI
ETF

ISHARES TR

265,051$31.2M2.1%$101.07+0.12%
8 qtrssince 2019-Q1
Increased
81
MGCMGC
ETF

VANGUARD MEGA CAP ETF

173,995$23.2M1.6%$114.12+8.88%
3 qtrssince 2020-Q2
Increased
65
SHVSHV
ETF

ISHARES SHORT TREASURY BOND

157,474$17.4M1.2%$90.67+2.54%
8 qtrssince 2019-Q1
Unchanged
0
SCHZSCHZ
ETF

SCHWAB US AGGREGATE BOND ETF

252,427$14.1M0.9%$23.71+0.30%
3 qtrssince 2020-Q2
Increased
61
AGGAGG
ETF

ISHARES TR

119,467$14.1M0.9%$99.08+0.46%
3 qtrssince 2020-Q2
Increased
61
IEFAIEFA
ETF

ISHARES CORE MSCI EAFE ETF

199,251$13.8M0.9%$54.11+9.58%
3 qtrssince 2020-Q2
Increased
59
VOEVOE
ETF

VANGUARD MID-CAP VALUE ETF

74,362$8.8M0.6%$79.31+166.04%
8 qtrssince 2019-Q1
Decreased
0
IWDIWD
ETF

ISHARES TR RUSSELL 1000 VALUE INDEX FUND

62,388$8.5M0.6%$102.41+20.26%
5 qtrssince 2019-Q4
Decreased
0
VOVO
ETF

VANGUARD MID-CAP ETF

32,750$6.8M0.5%$176.88+8.18%
3 qtrssince 2020-Q2
Increased
54
BILBIL
ETF

SPDR BLOOMBERG 1-3 MONTH T-B

64,581$5.9M0.4%$76.77+1.88%
8 qtrssince 2019-Q1
Unchanged
0
BKLNBKLN
ETF

INVESCO EXCH TRADED FD TR II

243,059$5.4M0.4%$14.85+5.07%
8 qtrssince 2019-Q1
Increased
37
SHYGSHYG
ETF

ISHARES TR

110,052$5M0.3%$32.13+3.22%
3 qtrssince 2020-Q2
Increased
52
VCITVCIT
ETF

VANGUARD INT-TERM CORPORATE

55,770$4.7M0.3%$67.77+18.43%
8 qtrssince 2019-Q1
Unchanged
0
$1.5B
AUM
26
Positions
Q4 2020
Filing
Rating · 3.5
Quarterly Portfolio Change
-21%Q3'19$860.7M-21%Q4'19$681M-7%Q1'20$633.5M+49%Q2'20$946.4M+17%Q3'20$1.1B+35%Q4'20$1.5B
Activity profile
$ moved · Q4'20
New0%Increased81%Decreased19%Exited0%
Composition
Equity vs derivatives
Equity100%Puts0%Calls0%
Holding period
Avg 1.2 years
<1Q0%1-4Q42%1-2Y58%2Y+0%

NEW YORK LIFE INVESTMENT MANAGEMENT LLC manages $1.5B across 26 positions as of Q4 2020. Top holdings: IQSU (21.6%), CLRG (18.8%), IQIN (16.1%). Fund DNA: Balanced Allocator. HoldingsIntel Rating: 3.5/5.0.

Q4 2020 Summary

Increased 15, trimmed 5. Top move: IQSU (INCREASED, conviction 97). Portfolio: $1.5B across 26 positions.

Top holdings by portfolio weight

Total AUM$1B
IQSU21.61%
CLRG18.78%
IQIN16.06%
HFXI10.39%
CSML9.02%
IQSI8.50%
HYLV3.83%
GVI2.09%
MGC1.56%
SHV1.17%
Other0.95%

Portfolio allocation by GICS sector

Sectors1
Unknown100.00%

Behavioral investing profile

Checking access…
Balanced Allocator- primarily Unknown
Compare DNA across all funds
7-dimension quality assessment
Strong(3.5 / 5.0)
Track Record71
Conviction40
Concentration43
Checking access…

Position Outcomes

Best and worst performing positions by estimated return

Cost basis estimates based on full filing history using quarter-end prices. Actual transaction prices are not disclosed in 13F filings.

Similar Funds

Funds with similar investing DNA

Accumulation Streaks

Positions with 2+ consecutive quarters of increases - persistent directional conviction.

Security
8Q
USHYUSHYISHARES BROAD USD HIGH YIELD
Q3 2024 Q2 2026+906,416 shares+$33.7M
7Q
APHAPHAMPHENOL CORP-CL A
Q4 2024 Q2 2026+10,995 shares+$19.8M
7Q
ATOATOATMOS ENERGY CORP
Q4 2024 Q2 2026+2,574 shares+$1.1M
Checking access…

Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used